Showing results (1151-1160 of 5,984) with videos related to

Sort By:
Pageof 599
Molecular Cancer Therapeutics|January 9, 2015
The MDM2 Inhibitor AMG 232 Demonstrates Robust Antitumor Efficacy and Potentiates the Activity of p53-Inducing Cytotoxic AgentsJude Canon, Tao Osgood, Steven H Olson, et al.
Molecular Cancer Therapeutics|October 26, 2014
Elevated LIM kinase 1 in nonmetastatic prostate cancer reflects its role in facilitating androgen receptor nuclear translocationKaterina Mardilovich, Mads Gabrielsen, Lynn McGarry, et al.
Molecular Cancer Therapeutics|October 29, 2014
Utilization of the Eμ-Myc mouse to model heterogeneity of therapeutic responseRachel E Rempel, Xiaolei Jiang, Paul Fullerton, et al.
Molecular Cancer Therapeutics|October 29, 2014
Cancer in silico drug discovery: a systems biology tool for identifying candidate drugs to target specific molecular tumor subtypesF Anthony San Lucas, Jerry Fowler, Kyle Chang, et al.
Molecular Cancer Therapeutics|December 16, 2014
Wee-1 kinase inhibition overcomes cisplatin resistance associated with high-risk TP53 mutations in head and neck cancer through mitotic arrest followed by senescenceAbdullah A Osman, Marcus M Monroe, Marcus V Ortega Alves, et al.
Molecular Cancer Therapeutics|December 17, 2014
Tumor-suppressor role of Notch3 in medullary thyroid carcinoma revealed by genetic and pharmacological inductionRenata Jaskula-Sztul, Jacob Eide, Sara Tesfazghi, et al.
Molecular Cancer Therapeutics|July 26, 2015
BGB-283, a Novel RAF Kinase and EGFR Inhibitor, Displays Potent Antitumor Activity in BRAF-Mutated Colorectal CancersZhiyu Tang, Xi Yuan, Rong Du, et al.
Molecular Cancer Therapeutics|July 26, 2015
Antitumor Activity and Acquired Resistance Mechanism of Dovitinib (TKI258) in RET-Rearranged Lung AdenocarcinomaChan Woo Kang, Kang Won Jang, Jinyoung Sohn, et al.
Molecular Cancer Therapeutics|January 2, 2015
Improved Circulating Tumor Cell Detection by a Combined EpCAM and MCAM CellSearch Enrichment Approach in Patients with Breast Cancer Undergoing Neoadjuvant ChemotherapyWendy Onstenk, Jaco Kraan, Bianca Mostert, et al.
Molecular Cancer Therapeutics|December 6, 2014
Optimizing the sequence of anti-EGFR-targeted therapy in EGFR-mutant lung cancerCatherine B Meador, Hailing Jin, Elisa de Stanchina, et al.
Pageof 599